IMDX
Insight Molecular Diagnostics
IMDX
IMDX
87 hedge funds and large institutions have $282M invested in Insight Molecular Diagnostics in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
90% more call options, than puts
Call options by funds: $1.49M | Put options by funds: $783K
45% more funds holding
Funds holding: 60 → 87 (+27)
0.63% more ownership
Funds ownership: 2.44% → 3.07% (+0.63%)
Holders
87
Holding in Top 10
2
Calls
$1.49M
Puts
$783K
Top Buyers
| 1 | +$28.2M | |
| 2 | +$9.97M | |
| 3 | +$9.78M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$7.1M |
| 5 |
BlackRock
New York
|
+$6.96M |
Top Sellers
| 1 | -$596K | |
| 2 | -$505K | |
| 3 | -$261K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$164K |
| 5 |
VF
Virtu Financial
New York
|
-$89K |